(Q39729097)

14 September 2017

Prostate cancer screening between low-income African-American and Caucasian men. (English)

1 reference

prostate cancer screening

14 September 2017

1 reference

1 reference

5

William J Blot

1 reference

14 September 2017

3

Lisa B Signorello

1 reference

14 September 2017

Jay H Fowke

1

1 reference

PubMed ID

16144667

14 September 2017

David Schlundt

series ordinal

2

1 reference

PubMed ID

16144667

14 September 2017

Flora A M Ukoli

series ordinal

4

1 reference

14 September 2017

1 September 2005

1 reference

14 September 2017

1 reference

14 September 2017

23

1 reference

14 September 2017

5

1 reference

14 September 2017

333-340

1 reference

14 September 2017

Cancer statistics, 2003.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.01.002

African American men and hereditary/familial prostate cancer: Intermediate-risk populations for chemoprevention trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.01.002

Biochemical recurrence after radical prostatectomy in black and white American men with a positive or negative family history of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.01.002

Prostate cancer biochemical recurrence stage for stage is more frequent among African-American than white men with locally advanced but not organ-confined disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.01.002

Explaining the difference in prostate cancer mortality rates between white and black men in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.01.002

Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.01.002

Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.01.002

Knowledge, beliefs, and prior screening behavior among blacks and whites reporting for prostate cancer screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.01.002

Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.01.002

Racial and ethnic differences in advanced-stage prostate cancer: the Prostate Cancer Outcomes Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.01.002

Prostate-specific antigen testing in black and white men: an analysis of medicare claims from 1991-1998.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.01.002

Overdiagnosis Due to Prostate-Specific Antigen Screening: Lessons From U.S. Prostate Cancer Incidence Trends

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.01.002

Changing relationship between socioeconomic status and prostate cancer incidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.01.002

Effects of health insurance and race on early detection of cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.01.002

Demographics and health-related factors of men receiving prostate-specific antigen screening in Utah

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.01.002

Urinary symptoms as a predictor for participation in prostate cancer screening among African American men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.01.002

The validity of male patients' self-reports regarding prostate cancer screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.01.002

The accuracy of primary care patients' self-reports of prostate-specific antigen testing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.01.002

Prostate-specific antigen test use reported in the 2000 National Health Interview Survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.01.002

Sociodemographic and health status characteristics with prostate cancer screening in a national cohort of middle-aged male veterans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.01.002

Racial differences in screening for prostate cancer in the elderly.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.01.002

Prostate cancer screening trends of New York State men at least 50 years of age, 1994 to 1997

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.01.002

Prostate-specific antigen screening in elderly men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.01.002

Analysing public preferences for cancer screening programmes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.01.002

Time costs associated with cervical cancer screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.01.002

To screen or not to screen, when clinical guidelines disagree: primary care physicians' use of the PSA test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.01.002

10.1016/J.UROLONC.2005.01.002

7 January 2021

Identifiers

DOI

1 reference

14 September 2017

1 reference

PubMed ID

16144667